Metraipolis › archive › dc_37e46b26953a

Cell-based immunotherapy for neurodegenerative disease: A promising avenue — Europe PMC PMID:41467421

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41467421
DOI
10.4103/nrr.nrr-d-25-00816
License (as archived)
solo-consultazione
Archived
2026-11-07T07:57:00.995Z
SHA-256 of the archived text
4e9cd967ba738f9f1a77bdbee29f692258ef7b263c128a3d3f1ed983cc4a85b3
Stable URL of this page
https://metraipolis.com/documento/dc_37e46b26953a

How to cite

Cell-based immunotherapy for neurodegenerative disease: A promising avenue — Europe PMC PMID:41467421 — Europe PMC (en), https://europepmc.org/article/MED/41467421 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_37e46b26953a (Metraipolis archive dc_37e46b26953a, sha256 4e9cd967ba738f9f1a77bdbee29f692258ef7b263c128a3d3f1ed983cc4a85b3)
BibTeX
@misc{dc37e46b26953a,
  title = {Cell-based immunotherapy for neurodegenerative disease: A promising avenue — Europe PMC PMID:41467421},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41467421},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_37e46b26953a; sha256 4e9cd967ba738f9f1a77bdbee29f692258ef7b263c128a3d3f1ed983cc4a85b3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41467421. Agents can read the archived copy with the MCP tool read_document.